Annette Tumolo
CIK 1717996 · Executive Vice President · last filed 2024-05-03
Annette Tumolo is an Executive Vice President who has filed 22 SEC Form 4 insider transactions across 3 companies since 2018. The most recent filing, for TBIO, was dated May 3, 2024. Across all open-market trades the lifetime net is −$6.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
BIO.B price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Telesis Bio Inc. (TBIO) Delisted | Director | 8,765 | $0.00 | $1 | $0 | 1 | 2024-05-03 |
| Telesis Bio Inc. (DNAY) Delisted | Director | 74,611 | $1.30 | $97.0K | $0 | 1 | 2022-07-22 |
| BIO.B | Executive Vice President | 6,139 | $389.98 | $2.39M | -$6.91M | 20 | 2021-11-15 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-03 | Telesis Bio Inc. (TBIO) Delisted | Grant (A) | +83,158 | $0 | EDGAR |
| 2022-07-22 | Telesis Bio Inc. (DNAY) Delisted | Grant (A) | +74,611 | $0 | EDGAR |
| 2021-11-15 | BIO.B | Mixed | — | -$2.96M | EDGAR |
| 2021-09-09 | BIO.B | Mixed | +302 | -$240.3K | EDGAR |
| 2021-09-08 | BIO.B | Mixed | +909 | -$695.1K | EDGAR |
| 2021-09-03 | BIO.B | Mixed | +283 | -$123.9K | EDGAR |
| 2021-08-27 | BIO.B | Sell (S) | −600 | -$475.5K | EDGAR |
| 2020-11-10 | BIO.B | Mixed | −423 | -$577.7K | EDGAR |
| 2020-09-14 | BIO.B | Mixed | +302 | -$150.5K | EDGAR |
| 2020-09-09 | BIO.B | Mixed | +1,047 | -$364.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.